BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 2984580)

  • 41. The effect of chronic treatment with peripheral benzodiazepine receptor ligands on behavior and GABAA/benzodiazepine receptors in rat.
    Rägo L; Saano V; Auvinen T; Adojaan A; Holma R; Airaksinen MM
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Oct; 346(4):432-6. PubMed ID: 1331816
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pro- and anti-convulsant drug effects in combination with the convulsant benzodiazepine Ro 5-4864.
    Pellow S; File SE
    J Pharm Pharmacol; 1985 Aug; 37(8):560-3. PubMed ID: 2864417
    [TBL] [Abstract][Full Text] [Related]  

  • 43. "Peripheral-type" binding sites for benzodiazepines in brain: relationship to the convulsant actions of Ro 5-4864.
    Weissman BA; Cott J; Jackson JA; Bolger GT; Weber KH; Horst WD; Paul SM; Skolnick P
    J Neurochem; 1985 May; 44(5):1494-9. PubMed ID: 2580949
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Does the benzodiazepine antagonist Ro 15-1788 reverse the actions of picrotoxin and pentylenetetrazole on social and exploratory behaviour?
    File SE; Pellow S
    Arch Int Pharmacodyn Ther; 1985 Oct; 277(2):272-9. PubMed ID: 2865937
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The direct enhancement of positive palatability by chlordiazepoxide is antagonized by Ro 15-1788 and CGS 8216.
    Treit D; Berridge KC; Schultz CE
    Pharmacol Biochem Behav; 1987 Apr; 26(4):709-14. PubMed ID: 3037568
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The anxiogenic action of benzodiazepine antagonists.
    File SE; Lister RG; Nutt DJ
    Neuropharmacology; 1982 Oct; 21(10):1033-7. PubMed ID: 6815546
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Actions of the beta-carboline ZK 93426 in an animal test of anxiety and the holeboard: interactions with Ro 15-1788.
    File SE; Pellow S; Jensen LH
    J Neural Transm; 1986; 65(2):103-14. PubMed ID: 3009709
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Behavioural effects of PK 8165 that are not mediated by benzodiazepine binding sites.
    File SE; Pellow S
    Neurosci Lett; 1984 Sep; 50(1-3):197-201. PubMed ID: 6093010
    [TBL] [Abstract][Full Text] [Related]  

  • 49. On the convulsant action of Ro 5-4864 and the existence of a micromolar benzodiazepine binding site in rat brain.
    File SE; Green AR; Nutt DJ; Vincent ND
    Psychopharmacology (Berl); 1984; 82(3):199-202. PubMed ID: 6326177
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effects of PK 11195, a ligand for benzodiazepine binding sites, in animal tests of anxiety and stress.
    File SE; Pellow S
    Pharmacol Biochem Behav; 1985 Nov; 23(5):737-41. PubMed ID: 3001779
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modification of seizures elicited by the benzodiazepine Ro 5-3663--a comparison with picrotoxin.
    File SE
    J Pharm Pharmacol; 1984 Dec; 36(12):837-40. PubMed ID: 6151978
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Discriminative stimulus properties of chlordiazepoxide and zolpidem. Agonist and antagonist effects of CGS 9896 and ZK 91296.
    Sanger DJ; Zivkovic B
    Neuropharmacology; 1987 May; 26(5):499-505. PubMed ID: 3037419
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Caffeine-induced anxiogenesis: the role of adenosine, benzodiazepine and noradrenergic receptors.
    Baldwin HA; File SE
    Pharmacol Biochem Behav; 1989 Jan; 32(1):181-6. PubMed ID: 2543990
    [TBL] [Abstract][Full Text] [Related]  

  • 54. RO5-4864, a ligand for benzodiazepine micromolar and peripheral binding sites: antagonism and enhancement of behavioural effects.
    File SE; Pellow S
    Psychopharmacology (Berl); 1983; 80(2):166-70. PubMed ID: 6308704
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interaction of the benzodiazepine antagonists, CGS 8216 and Ro 15-1788, with central adenosine A-1 receptors.
    Williams M; Risley EA
    Arch Int Pharmacodyn Ther; 1982 Nov; 260(1):50-3. PubMed ID: 6299218
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interactions of Ro 15-1788, CGS 8216 and diazepam on head-turning in rats.
    Goldstein JM; Sutton EB; Malick JB
    Life Sci; 1986 Feb; 38(5):459-63. PubMed ID: 3080650
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anticonflict action of sodium valproate. Interaction with convulsant benzodiazepine (Ro 5-3663) and imidazodiazepine (Ro 15-1788).
    Myslobodsky M; Feldon J; Lerner T
    Life Sci; 1983 Jul; 33(4):317-21. PubMed ID: 6135965
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CGS 8216 treatment decreases central-type benzodiazepine receptors in rat brain.
    Deckert J; Estall LB; Marangos PJ; Cooper SJ
    Eur J Pharmacol; 1987 Oct; 142(3):457-60. PubMed ID: 2828077
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Spontaneous and RO 15-1788-induced reversal of subsensitivity to GABA following chronic benzodiazepines.
    Gonsalves SF; Gallager DW
    Eur J Pharmacol; 1985 Apr; 110(2):163-70. PubMed ID: 2859214
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Midazolam-induced increase in NaCl solution ingestion: differential effect of the benzodiazepine antagonists Ro 15-1788 and CGS 8216.
    Falk JL; Tang M
    Pharmacol Biochem Behav; 1984 Dec; 21(6):965-8. PubMed ID: 6441170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.